SUMMARY
Discontinuation of sedatives for ventilator weaning and extubation can be associated with hyperdynamic responses, including hypertension and tachycardia. We examined the effects of a maintained low dose of remifentanil infusion on cardiovascular responses and coughing during extubation in postoperative intensive care unit patients sedated with propofol-remifentanil.
Fifty patients who required mechanical ventilation after major abdominal surgery were randomised into remifentanil group (n=25) or control group (n=25). Sedation during mechanical ventilation was maintained with remifentanil and propofol via a target-controlled infusion system. These drugs were titrated to the target sedation range, bispectral index values of 60 to 75 and Richmond Agitation Sedation Scale values of -3 to -2. When weaning was initiated, propofol was stopped in both groups. In the control group, remifentanil infusion was also stopped; in the remifentanil group, remifentanil infusion was maintained until extubation at a target effect site concentration of 1.0 ng/ml. Extubation was performed if the patient's respiratory, haemodynamic states were stable and if the patient was able to follow commands. heart rate, mean arterial pressure and cough severity were evaluated.
The mean arterial pressure, heart rate and cough severity did not differ between the two groups during extubation. The time from stopping of propofol infusion to extubation was significantly longer in the remifentanil group compared to that in the control group (P=0.020).
Maintaining a low-dose remifentanil infusion during ventilator weaning delayed tracheal extubation without any differences in haemodynamic changes or coughing in postoperative intensive care unit patients. and coughing during extubation 10, 11 . In another study, administration of a low dose of remifentanil at a rate one-tenth of the maintenance rate reduced coughing and tachycardia during the emergence phase without compromising recovery from anaesthesia 12 . Even though remifentanil has been used extensively to reduce haemodynamic changes and coughing during emergence from general anaesthesia [10] [11] [12] [13] [14] , there are no comprehensive data for its use in weaning from mechanical ventilation in ICU patients after surgery. The aim of this randomised trial was to investigate the efficacy and safety of maintaining remifentanil at a Ce of 1.0 ng/ml during weaning from mechanical ventilation after major abdominal surgery.
MATERIALS AnD METhODS
This study was approved by the Institutional Ethics Committee of Yonsei University Medical Centre and is registered at http://clinicaltrials.gov (registration number nCT01152515). This study was conducted between May 2010 and February 2011 in the surgical ICU (SICU).
Patients were eligible for enrolment if they were 20 years of age or older, were classified as American Society of Anesthesiologists (ASA) class I to III, had received major abdominal surgery and were intubated and expected to require mechanical ventilation for a further eight to 32 hours. As enrolled patients were intubated, written informed consent was obtained from patients' legal surrogates before randomisation. Patients were excluded from the study if they were haemodynamically unstable, required a neuromuscular blocking agent to facilitate mechanical ventilation or had pneumonia, chronic obstructive pulmonary disease, asthma, risk of aspiration or renal insufficiency (estimated glomerular filtration rate <60 ml/minute/1.73 m 2 ). Patients with a history of allergy to opioids or propofol were also excluded from the study.
At our centre, induction of general anaesthesia is routinely performed with remifentanil 0.5 to 1 μg/kg, propofol 1.5 to 2.0 mg/kg and rocuronium bromide 0.8 to 1 mg/kg. Anaesthesia was maintained with remifentanil 0.05 to 0.15 μg/kg/min and 1.5 to 2% end-tidal sevoflurane in 50% O 2 /air. For laparotomy surgery, a rocuronium infusion was initiated at a rate of 3 to 6 μg/kg/min with train-of-four monitoring. We applied either epidural or intravenous patientcontrolled analgesia (PCA) in all patients who underwent open surgery. Fentanyl 20 μg/kg and 0.75% ropivacaine 30 ml are used for epidural PCA and fentanyl 20 μg/kg and ondansetron 12 mg are used for intravenous PCA. The drugs were mixed with normal saline in a total volume of 100 ml. The PCA devices are programmed to yield a basal infusion rate of 2 ml/hour and a bolus dose of 0.5 ml with a lockout time of 15 minutes. After termination of the operation, all anaesthetic drugs were discontinued and PCA was started, and patients were transferred to the SICU.
After arrival in the SICU, patients who were expected to require mechanical ventilation for eight to 32 hours after major abdominal surgery were randomly assigned on a 1:1 basis to either the control group (n=25) or the remifentanil group (n=25) using a random number sequence. All patients were sedated with remifentanil (Ultiva ® , GlaxoSmithKline, UK) and propofol (Fresofol ® , Fresenius Kabi Korea Ltd, Korea) infusion through a commercial total intravenous anaesthesia pump (Orchestra ® Base Primea, Fresenius-Vial, France). The pumps were operated according to the Schnider model for propofol and the Minto model for remifentanil. The remifentanil and propofol infusions were started at a Ce of 1.0 ng/ml upon arrival in the SICU and were increased or decreased according to a target bispectral index (BIS; A-2000 TM XP, Aspect Medical Systems, USA) value range of 60 to 75 and Richmond Agitation Sedation Scale (RASS) scores of -3 and -2 15 . The infusion port for propofol and remifentanil was connected as close as possible to the intravenous catheter. Mechanical ventilation was maintained at a tidal volume of 6 ml/kg of predicted body weight, frequency of 15 to 18 /minute and FiO 2 of 0.4 to 0.5.
The weaning process was initiated the day after surgery if no surgical complications were anticipated and if there were no signs of respiratory or haemodynamic impairment. When weaning was commenced (time zero), propofol infusion was stopped in both groups. In the control group, remifentanil infusion was also stopped; in the remifentanil group, remifentanil infusion was maintained at a Ce of 1.0 ng/ml until extubation. For blindness, the total intravenous anaesthesia pump was covered with a surgical towel. Extubation was performed by the anaesthetist who was blind to the study group when the patient was fully awake (BIS value of >80 and RASS ≥-1), with a tidal volume >5 ml/kg, a respiratory rate of 10 to 25 breaths/minute, P a O 2 >80 mmhg, P a CO 2 <45 mmhg and no haemodynamic impairment. After extubation, remifentanil infusion in the remifentanil group was discontinued.
Demographic data including age, gender, height, weight and history of hypertension, diabetes mellitus, coronary artery occlusive disease and stroke were recorded. The type of surgery, duration of anaesthesia and use of vasopressor during sedation in the SICU were also recorded. The times to BIS >80, RASS ≥-1 and extubation were measured from 'time zero.' Invasive mean arterial pressure (MAP) and heart rate were recorded before the start of sedation, 30 minutes after sedation, at 'time zero', 5 minutes after 'time zero', immediately after extubation, 5 minutes after extubation and 10 minutes after extubation. Grade of cough was assessed on a four-point scale (0=no coughing, 1=single cough, 2=more than one episode of nonsustained coughing, 3=sustained and repetitive coughing with head lift). The visual analogue scale score (VAS; 0 as no pain and 10 as worst Sample size calculations were based on a previous study 11 . Standard deviation of MAP at the time of extubation was 17 mmhg in the control group. To detect a 15 mmhg in MAP at the time of extubation (two-sided α of 5% and power of 80%), 21 subjects were required in each group. We included 25 patients per group to allow for possible dropouts.
Statistical analysis was performed using PASW Statistics 18 (SPSS Inc., Chicago, IL, USA) and SAS software 9.2 (SAS Inc., Cary, nC, USA). The normality of distribution was assessed with a q-q plot and the Shapiro-Wilk test. Parametric data were analysed using an independent t-test. non-parametric data were analysed using the Mann-Whitney U test. Categorical variables were evaluated using the χ 2 test or Fisher's exact test when appropriate. Repeatedly measured variables (MAP and heart rate) were analysed using linear mixed models with a Bonferroni correction. All values were expressed as mean±SD, median (range) or the number of patients. A P value <0.05 was considered statistically significant.
RESULTS
Of a total of 62 patients assessed for eligibility, 50 subjects were enrolled after randomisation and none were eliminated from data collection ( Figure  1 ). Patients and operative characteristics were similar between the two groups ( Table 1) .
haemodynamic changes during sedation and ventilator weaning are shown in Figure 2 . The MAP and heart rate values did not differ between the two groups at any of the time points including extubation. These values significantly decreased after sedation and increased during extubation in both groups compared to the level at the beginning and end of the propofol infusion.
Data related to sedation and ventilator weaning are provided in Table 2 . There were no significant differences between the groups regarding the time from discontinuation of propofol infusion to BIS >80 or RASS ≥-1. However, the time from discontinuation of propofol infusion to extubation was significantly longer in the remifentanil group compared to that in the control group (P=0.020). We did not observe any differences between the two groups with respect to total infused dose of propofol or remifentanil, durations of sedation and mechanical ventilation or length of ICU stay. VAS score was similar and only one patient in each group complained of nausea without vomiting after extubation and was administered antiemetics. The grades of coughing during extubation were similar between the groups ( Table 3 ).
DISCUSSIOn
The results of this randomised clinical trial suggest that maintaining a target controlled infusion of remifentanil at an effect site of 1.0 ng/ml during ventilator weaning and tracheal extubation in postoperative ICU patients sedated with propofol-remifentanil is not effective in reducing hyperdynamic responses during extubation after laparotomy. Moreover, even though a remifentanil Ce of 1.0 ng/ml is a low effect site concentration, it could delay tracheal extubation.
Some patients require short-term mechanical ventilatory support in ICU after major abdominal surgery. The majority of these patients require analgesia and sedation for controlling pain, relieving agitation and anxiety and aiding compliance with mechanical ventilation 1 . In our centre, most patients are extubated on the day after surgery if no surgical complications are anticipated and if there are no signs of respiratory or haemodynamic impairment. Therefore, short-term sedative agents are necessary.
The combination regimen of propofol and remifentanil significantly reduced the duration of mechanical ventilation and the length of ICU stay compared to those of midazolam and fentanyl 5 . Propofol provides sedation and hypnosis in a dose dependent manner, and its pharmacokinetic properties are characterised by a rapid onset and short duration of action. The rapid recovery after discontinuation of propofol makes it an attractive sedative in the ICU, particularly for patients who need only short-term sedation 16 . however, it can cause cardiovascular depression and should be used with caution in patients who are hypotensive, hypovolaemic or haemodynamically unstable 17 . About 20% of patients (11 of 50) in our study required the use of vasopressor during propofol sedation. Even though we did not investigate the underlying reason for the requirement for a vasopressor, many Values are number of patients. Coughing grade was recorded on a four-point scale, with 0=no coughing, 1=single cough, 2=more than one episode of non-sustained coughing, 3=sustained and repetitive coughing with head lift. reasons could exist for hypotension after surgery, such as blood and fluid loss during surgery, fever, sepsis or medications.
Remifentanil is a useful analgesic in ICU patients, especially in those with renal or liver dysfunction, because of its organ independent metabolism via non-specific blood and tissue esterases and short context-sensitive half-time of three to four minutes 2 . Analgesia based sedation with remifentanil provided effective sedation and rapid extubation without the need for propofol in most patients compared with those with fentanyl 4 . In the present study, none of the patients required additional analgesics or sedatives during the sedation period. The combination regimen of propofol and remifentanil was safe and effective for sedation during mechanical ventilation in the postoperative patients who were haemodynamically stable before sedation.
During sedation, propofol and remifentanil were titrated to the target sedation range BIS values of 60 to 75 and an RASS ranging from -3 (moderate sedation: movement or eye opening response to voice but no eye contact) to -2 (light sedation: briefly awakens with eye contact to voice <10 seconds). The RASS measurement takes less than 20 seconds to perform, requires minimal training and includes responses to verbal and physical stimulation, which may be helpful to the clinician when titrating medications 18 . This test also demonstrates excellent reliability and criterion, construct and face validity 19 . The effects of sedative drugs on the central nervous system can be directly evaluated through the analysis of electroencephalographic patterns. Among electroencephalographic derived parameters, BIS is now an acceptable tool for the evaluation of depth of sedation. BIS monitoring provides a continuous and observer-independent digital value representing cerebral activity. A BIS score between 90 to 100 reflects an awake state, 80 to 70 reflects light sedation, 60 reflects moderate sedation and 40 reflects anaesthesia 20 . An average BIS score of 66 with a 95% confidence interval of 60 to 72 has been correlated with deep sedation during mechanical ventilation in the ICU 21 . From the results of this study, we decided that the target BIS value during sedation was 60 to 75. We measured the time between discontinuation of propofol and the achievement of a BIS value >80 or a RASS score ≥-1 because these conditions (drowsy: not fully alert but has sustained awakening, eye opening/contact to voice >10 seconds) could be considered an awake state. Maintenance of a low dose of remifentanil infusion (Ce of 1.0 ng/ml) during ventilator weaning did not affect these times.
During tracheal extubation, adverse events such as hypertension, tachycardia, coughing, increased intraabdominal pressure and abdominal wound separation may be induced [7] [8] [9] . Therefore, smooth extubation with no hyperdynamic response is desirable after abdominal surgery. Intravenous opioids could be helpful for smooth extubation 9 . Several studies have evaluated the effect of maintained remifentanil during emergence from general anaesthesia. Maintenance of remifentanil at a Ce of 1.5 ng/ml during emergence was shown to reduce haemodynamic changes and coughing during extubation without delaying recovery from anaesthesia 11 . however, in another study of maintenance of remifentanil at a Ce of 1.5 ng/ml, the emergence time and length of stay in the post-anaesthesia care unit were prolonged even though it was beneficial for haemodynamic stability and cough prevention 10 .
These previous studies took place in an operating room setting and the patients received low-risk elective endoscopic sinus surgery or thyroidectomy 10, 11 . In addition, the patients had ASA physical status I-II and had an average age in their forties. We anticipated that the patients who needed ICU care after surgery would be older and have more problems. Patients in our study were about ten years older than those in previous studies. We also included ASA physical status III and emergency surgery. Therefore, we decided to maintain remifentanil at a Ce of 1.0 ng/ml, a lower dose than Ce of 1.5 ng/ml used in previous studies. however, this Ce of 1.0 ng/ml was not sufficient to prevent haemodynamic changes or coughing during extubation in postoperative ICU patients.
Our results are in agreement with previous findings that a Ce of 1.0 ng/ml is not effective for preventing haemodynamic changes or coughing during emergence from general anaesthesia 10 . Contrary to a previous finding of no delay in the time to extubation at a Ce of 1.0 ng/ml in the operating room 10 , a Ce of 1.0 ng/ml was found to delay the time to extubation in the ICU setting. The reasons for these differing results may be attributed to the different patient population and a variable and uncontrollable environment in the ICU compared to that of the more controlled operating room. Therefore, maintenance of remifentanil infusion during ventilator weaning may not be a good choice in ICU patients.
The limitations of this study are as follows. First, we tested only one concentration of remifentanil. A higher Ce of remifentanil may be effective for reducing haemodynamic changes. In our patients, the average Ce of remifentanil and propofol was 1.0 ng/ml at 30 minutes after sedation and 1.2 ng/ml just before the start of weaning. These concentrations were much lower than those in the previous studies 10, 11 . Therefore, maintaining remifentanil at a Ce of 1.5 ng/ml during extubation, a higher concentration than that of sedation, may not be beneficial to ICU patients. In addition, this higher dose may induce an additional delay when weaning from mechanical ventilation. Second, we used Ce as a predicted concentration at the effect site without measuring the plasma concentration of remifentanil. however, the level of bias may be acceptable because we used Minto's pharmacokinetic model to determine the Ce of remifentanil, a common model that is better suited to a wider and more heterogeneous population of patients 22 . Third, the management of pain was not controlled. Even though it was not statistically significant, the number of patients with epidural PCA was higher in the control group than remifentanil group (six versus four respectively). This could have influenced our results. However, as median VAS scores after extubation were similar between the groups, the effects of pain control method on the haemodynamic changes during extubation could be negligible.
In conclusion, maintaining a low dose remifentanil infusion at a Ce of 1.0 ng/ml during weaning from mechanical ventilation delayed tracheal extubation without any difference in haemodynamic changes or coughing in postoperative ICU patients.
